Encysive To Cut U.S. Work Force By 70 Percent To Curb Cash Flow
This article was originally published in The Pink Sheet Daily
Executive Summary
Company also appoints George Cole to CEO, replacing Bruce Given, following on the heels of an FDA “approvable” letter for Thelin.